Champions Oncology Inc (CSBR)

NASDAQHealth CareBiotechnologySnapshot 2026-09-04

$5.22-1.14%

Close 2026-09-04 · 1-day change

QuarterlyIQ Insights · CSBR

News & Events

Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.

Type

Direction

26 matches

2026-07-27Item 2.02
CSBR — earnings in line
in this Current Report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Earnings preannouncementearnings inlineneutral
2026-03-30Item 5.02
CSBR — CEO transition
Director — Dr. Philip Breitfeld: Dr. Philip Breitfeld resigned from the Board of Directors.
Executive changedepartureneutral
2026-03-12Item 2.02
CSBR — earnings miss
in this Current Report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Earnings preannouncementearnings missnegative
2025-12-15Item 2.02
CSBR — earnings beat
in this Current Report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Earnings preannouncementearnings beatpositive
2025-09-15Item 2.02
CSBR — earnings beat
in this Current Report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Earnings preannouncementearnings beatpositive
2025-07-23Item 2.02
CSBR — earnings miss
in this Current Report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Earnings preannouncementearnings missnegative
2025-07-21Item 5.02
CSBR — CEO transition
Chief Executive Officer — Robert Brainin: Champions Oncology, Inc. hired Robert Brainin as the new Chief Executive Officer.
Executive changeexternal hirepositive
2025-03-11Item 2.02
CSBR — earnings beat
in this Current Report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Earnings preannouncementearnings beatpositive
2024-12-11Item 2.02
CSBR — earnings beat
in this Current Report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Earnings preannouncementearnings beatpositive
2024-10-03Item 5.02
CSBR — President transition
President — Mr. Brady Davis: Mr. Brady Davis, the President, passed away unexpectedly.
Executive changedeathnegative
2024-09-11Item 2.02
CSBR — earnings beat
in this Current Report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Earnings preannouncementearnings beatpositive
2024-07-18Item 2.02
CSBR — earnings beat
in this Current Report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Earnings preannouncementearnings beatpositive
2024-03-12Item 2.02
CSBR — earnings miss
in this Current Report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Earnings preannouncementearnings missnegative
2023-12-12Item 2.02
CSBR — earnings beat
in this Current Report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Earnings preannouncementearnings beatpositive
2023-10-17Item 5.02
CSBR — President transition
President — Brady Davis: Champions Oncology hired Brady Davis as President with significant experience in healthcare and leadership roles.
Executive changeexternal hirepositive
2023-09-13Item 2.02
CSBR — earnings miss
in this Current Report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Earnings preannouncementearnings missnegative
2023-07-24Item 2.02
CSBR — earnings miss
in this Current Report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Earnings preannouncementearnings missnegative
2023-04-05Item 8.01
CSBR — share buyback announced
Other Events. On March 29, 2023, the Board of Directors approved a share repurchase program authorizing the Company to purchase up to an aggregate of $5 million of the Company’s common stock. The share repurchase program is in accordance with Rule 10b-18 of the Exchange Act. Subject to applicable rules and regulations, the shares may be purchased from time to time in the open market as permitted under applicable rules and regulations.
Capital allocationbuyback announcedpositive
2023-03-15Item 2.02
CSBR — earnings miss
in this Current Report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Earnings preannouncementearnings missnegative
2022-12-13Item 2.02
CSBR — earnings in line
in this Current Report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Earnings preannouncementearnings inlineneutral
2022-09-08Item 2.02
CSBR — earnings miss
in this Current Report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Earnings preannouncementearnings missnegative
2022-07-21Item 2.02
CSBR — earnings miss
in this Current Report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Earnings preannouncementearnings missnegative
2022-03-15Item 2.02
CSBR — earnings beat
in this Current Report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Earnings preannouncementearnings beatpositive
2021-12-13Item 2.02
CSBR — earnings in line
in this Current Report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Earnings preannouncementearnings inlineneutral
2021-09-13Item 2.02
CSBR — earnings in line
in this Current Report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Earnings preannouncementearnings inlineneutral

Coming next

General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.

Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.